1818P Final results from a randomized phase II study of cabazitaxel (CBZ) versus an androgen receptor targeted agent (ARTA) in patients with poor-prognosis castration-resistant prostate cancer (mCRPC)
| Autor: | van der Zande, K., van der Noort, V., Busard, M., Hamberg, P., Ras - van Spijk, S., de Feijter, J., Dezentje, V., Tascilar, M., Houtsma, D., Beeker, A., van den Berg, P., ten Oever, D., Oving, I.M., Zwart, W., Bergman, A.M. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S985-S985 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|